![](https://test.globalgenomics.org/wp-content/uploads/2023/08/Gad-Rennert.png)
Gad Rennert, M.D., Ph.D.
Steering Committee, G2MC
- Director, Clalit National Cancer Control Center and National Personalized Medicine Program, Israel
- Professor and Chairman, Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Israel
Dr. Rennert’s research interests are in molecular/genetic cancer epidemiology, cancer prevention and screening, and in molecular or personalized targeted medicine. Cancer chemoprevention studies are another focus of his scientific work. He is currently studying and coordinating the cancer screening activities on a national level in Israel and studying unique founder mutations leading to cancer through the Familial Cancer Consultation Service which cares for thousands of mutation carriers.
Dr. Rennert’s work involves a deep epidemiological evaluation of more than 40,000 study participants combined with massive genetic testing using RT-PCR, Sanger sequencing, deep next-generation sequencing, microarray testing, multi-gene expression panels studies, Onco-chip multi-SNP panel, whole exome analysis and other laboratory methods.